RSR13
Term · Oncology and biomedicine · MLC-T-ONC-007508
A substance being studied in the treatment of brain tumors and some other types of cancer. It increases the amount of oxygen in tumor tissues, which may make the tumor cells easier to kill with radiation therapy. RSR13 is a type of radiosensitizing agent. Also called efaproxiral.
| Identifier | MLC-T-ONC-007508 |
|---|---|
| Field | Oncology and biomedicine |
| Expansions | efaproxiral |
| References | NCI Dictionary of Cancer Terms |
Record as JSON
{
"id": "MLC-T-ONC-007508",
"term": "RSR13",
"field": "Oncology and biomedicine",
"definition": "A substance being studied in the treatment of brain tumors and some other types of cancer. It increases the amount of oxygen in tumor tissues, which may make the tumor cells easier to kill with radiation therapy. RSR13 is a type of radiosensitizing agent. Also called efaproxiral.",
"expansions": [
"efaproxiral"
],
"references": [
"NCI Dictionary of Cancer Terms"
],
"url": "https://mlchart.com/terminology/oncology/rsr13/"
}
Record 14,593 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.